Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why OrganiGram Holdings Dove on Tuesday

By Eric Volkman - Jan 12, 2021 at 6:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's latest set of quarterly results isn't giving investors much of a high.

What happened

Cannabis company OrganiGram Holdings ( OGI -6.67% ) took a tumble on the market. In the wake of the Canadian company's release of its latest quarterly results, it closed Tuesday nearly 11% lower.

So what

Marijuana stock investors are starving for encouraging signs of growth and current/potential profitability in their companies. With OrganiGram's first quarter of fiscal 2021 figures, unfortunately, they didn't get any.

For the quarter, the company's net revenue totaled just under 19.3 million Canadian dollars ($15.1 million), which was 23% down on a year-over-year basis and 5% below that of the previous quarter. Net loss, meanwhile, was CA$34.3 million ($26.9 million) against the year-ago shortfall of CA$863,000 ($676,000) and narrower than Q4 2020's deficit of CA$38.6 million ($30.2 million).

Gloved hand holding marijuana leaf in front of Canadian flag.

Image source: Getty Images.

According to Zack's Investment Research, that top line missed the average analyst estimate. Prognosticators following the stock were also expecting a considerably narrower loss.

OrganiGram attributed the revenue slide to "significantly" lower take in the wholesale segment from licensed producers and a lower average selling price overall for marijuana during the quarter. 

Now what

OrganiGram just doesn't seem to be able to counter the price erosion in the Canadian market. What it calls "Rec 2.0" products -- the derivatives such as cannabis-infused candies and drinks that were legalized in 2019 -- helped fuel the company's recreational marijuana revenue sales, which rose 30% year over year. That is only a short-term sugar rush, however, as in the year-ago quarter those goods hadn't yet come to market.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

OrganiGram Holdings Stock Quote
OrganiGram Holdings
$1.82 (-6.67%) $0.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/04/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.